DK0948961T3 - Calcium-containing effervescent tablet with an antihistaminic active ingredient - Google Patents

Calcium-containing effervescent tablet with an antihistaminic active ingredient

Info

Publication number
DK0948961T3
DK0948961T3 DK99106452T DK99106452T DK0948961T3 DK 0948961 T3 DK0948961 T3 DK 0948961T3 DK 99106452 T DK99106452 T DK 99106452T DK 99106452 T DK99106452 T DK 99106452T DK 0948961 T3 DK0948961 T3 DK 0948961T3
Authority
DK
Denmark
Prior art keywords
calcium
active ingredient
effervescent tablet
containing effervescent
antihistaminic active
Prior art date
Application number
DK99106452T
Other languages
Danish (da)
Inventor
Klaus Dr Dandl
Thomas Dr Hein
Siegfried Dr Rothenberger
Original Assignee
Gradinger F Hermes Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gradinger F Hermes Pharma filed Critical Gradinger F Hermes Pharma
Application granted granted Critical
Publication of DK0948961T3 publication Critical patent/DK0948961T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Effervescent tablets containing antihistamines also contain calcium.
DK99106452T 1998-03-31 1999-03-29 Calcium-containing effervescent tablet with an antihistaminic active ingredient DK0948961T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19814392A DE19814392A1 (en) 1998-03-31 1998-03-31 Effervescent tablet containing calcium with an antihistamine as active ingredient

Publications (1)

Publication Number Publication Date
DK0948961T3 true DK0948961T3 (en) 2004-08-30

Family

ID=7863105

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99106452T DK0948961T3 (en) 1998-03-31 1999-03-29 Calcium-containing effervescent tablet with an antihistaminic active ingredient

Country Status (5)

Country Link
EP (1) EP0948961B1 (en)
AT (1) ATE269061T1 (en)
DE (2) DE19814392A1 (en)
DK (1) DK0948961T3 (en)
ES (1) ES2223150T3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111780B8 (en) * 2001-03-13 2005-02-10 Isaak Dr. Abramov Effervescent tablet, pill or dragee, as well as the process for its preparation
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
CN102614178B (en) * 2012-03-09 2015-09-30 重庆康刻尔制药有限公司 A kind of loratadine composition of medicine, oral cavity disintegration tablet and application thereof
CH710361B1 (en) * 2014-11-12 2018-12-28 Laboratoires Biofar Sarl Sodium-ion-free effervescent tablet or effervescent powder with high calcium ion content (CaCO3).

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
WO1991004757A1 (en) * 1989-10-02 1991-04-18 Cima Labs, Inc. Effervescent dosage form and method of administering same
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
IT1264696B1 (en) * 1993-07-09 1996-10-04 Applied Pharma Res PHARMACEUTICAL FORMS INTENDED FOR ORAL ADMINISTRATION ABLE TO RELEASE ACTIVE SUBSTANCES AT A CONTROLLED AND DIFFERENTIATED SPEED
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
DE19814392A1 (en) 1999-10-07
EP0948961B1 (en) 2004-06-16
EP0948961A2 (en) 1999-10-13
EP0948961A3 (en) 2001-04-04
DE59909714D1 (en) 2004-07-22
ATE269061T1 (en) 2004-07-15
ES2223150T3 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
NO971206D0 (en) Prolonged-frigjöringsformulering
DK1020462T3 (en) Heterocyclic compounds and anti-tumor agents containing these as active ingredient
DE69927694D1 (en) ORAL BIOADHESIVE TABLET WITH EXTENDED ACTIVE SUBSTANCE
DE69202584D1 (en) Bioabsorbable medical implants.
FR2709246B1 (en) Dynamic implanted spinal orthosis.
NO20053106D0 (en) Oral, extended-release analgesic dosage form.
ITBO910024A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
EE200100293A (en) Controlled release dosage form containing GnRH-II
DK1037634T3 (en) Oral administration comprising a proton pump inhibitor (e.g. pantoprazo)
FI921606A0 (en) MICROPEROXIDE INNEHAOLLANDE HEMOPEPTID SOM ACTIVE COMPONENT.
DK0698393T3 (en) 3 - / - menthoxypropane-1,2-diol as a solubilizer and topical preparation containing the same
IS5524A (en) Oral prolonged-release tablets
PT857718E (en) ENDOTHELINE ANTAGONIST
MXPA02006826A (en) Cell division inhibitors and process for producing the same.
FR2689396B1 (en) Active oxygen scavenger.
ATE260650T1 (en) ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
DK1140031T3 (en) Pharmaceutical composition for controlled release with tilidine mesylate as active substance
NO20011217D0 (en) Dosage form comprising liquid formulation
NO20006646D0 (en) Amino acid derivatives and drugs containing the same as active ingredient
ATE285753T1 (en) CHEWABLE TABLET CONTAINING LYSINE
DE59300688D1 (en) Tablet with improved bioavailability containing dichloromethylene diphosphonic acid as active ingredient.
DE60006558D1 (en) STABLE SOLUTION OF CALCITRIOL FOR PACKAGING IN VIALS
DK0948961T3 (en) Calcium-containing effervescent tablet with an antihistaminic active ingredient
DK0469440T3 (en) Solid oral dosage forms containing as active ingredient ifosamide
DK0511800T3 (en) Pharmaceutical formulation containing dirithromycin